RT Journal Article
SR Electronic
T1 SARS-CoV-2 Vaccine-Induced Antibody Response and Reinfection in Persons with Past Natural Infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.18.21257259
DO 10.1101/2021.05.18.21257259
A1 Nitu Chauhan
A1 Ajeet Singh Chahar
A1 Prem Singh
A1 Neel Sarovar Bhavesh
A1 Ravi Tandon
A1 Rupesh Chaturvedi
YR 2021
UL http://medrxiv.org/content/early/2021/05/18/2021.05.18.21257259.abstract
AB Several studies have shown that subjects with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection had significantly higher antibody titers than previously uninfected vaccinees after vaccination with mRNA vaccine. Yet no information is available for other vaccines.In the current observational cohort study, 105 health care workers who had received Covishield an Adeno associated viral vector-based DNA vaccine were enrolled at Sarojini Nadu Medical College Agra, India. The study included 40 (23 men and 17 women) subjects with a previous history of SARS-CoV-2 infection and 65 participants (39 men and 26 women) who were not infected previously. Both the groups received the adenovirus vector vaccine ChAdOx1-S recombinant vaccines (Covishield, Astra Zeneca). The levels of SARS-CoV-2-anti-spike-IgG-antibodies titer were measured using Electrochemiluminescence immunoassay on Roche platform as arbitrary units per milliliter (AU/ml).After 28 days of the second dose, subjects with no previous SARSCoV-2 infection showed a significantly lower level of circulating anti-spike-IgG-antibody titers compared to previously infected participants. After the second dose, we also observed a significant increase in SARS-CoV-2 infection in subjects with no prior history of SARS-CoV-2 infection compared to subjects with a previous history of natural infection.The most important observation of the study is a low percentage of infection in previously infected subjects. The finding of the study also indicates the presence of robust humoral memory response in previously infected patients.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is part of ongoing government sponsored health worker immunization program.Funding StatementNo external funding is provided to the institution or authors for submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethics Committee, S. N. Medical College Agra, E. C. Registration No.: ECR/1409/Inst?UP/2020 Study Approval No.: SNMC/IEC/2021-09All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll Raw and analyzed data are available at the Department of Transfusion Medicine, S. N. Medical College, Agra in excel format.